WP
PFE icon

Woodline Partners’s Pfizer PFE Stock Holding History

Woodline Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.9M Buy
2,154,713
+120,871
+6% +$3.16M 0.16% 169
2026
Q1 		$57.1M Buy
2,033,842
+405,567
+25% +$10.8M 0.22% 114
2025
Q4 		$40.5M Buy
1,628,275
+170,169
+12% +$4.29M 0.16% 172
2025
Q3 		$37.2M Buy
1,458,106
+32,436
+2% +$801K 0.17% 160
2025
Q2 		$34.6M Buy
1,425,670
+222,325
+18% +$5.18M 0.18% 156
2025
Q1 		$30.5M Sell
1,203,345
-115,145
-9% -$3.01M 0.2% 159
2024
Q4 		$35M Buy
1,318,490
+191,957
+17% +$5.21M 0.24% 132
2024
Q3 		$32.6M Buy
1,126,533
+55
+0% +$1.6K 0.27% 117
2024
Q2 		$31.5M Buy
1,126,478
+1,757
+0.2% +$48.4K 0.3% 102
2024
Q1 		$31.2M Sell
1,124,721
-366,317
-25% -$10.2M 0.29% 108
2023
Q4 		$42.9M Buy
1,491,038
+1,191,152
+397% +$36M 0.47% 62
2023
Q3 		$9.95M Buy
299,886
+24,827
+9% +$878K 0.12% 225
2023
Q2 		$10.1M Sell
275,059
-38,578
-12% -$1.5M 0.12% 207
2023
Q1 		$12.8M Buy
313,637
+158
+0.1% +$6.82K 0.17% 166
2022
Q4 		$16.1M Sell
313,479
-313,374
-50% -$15M 0.21% 137
2022
Q3 		$27.4M Hold
626,853
– – 0.38% 73
2022
Q2 		$32.9M Hold
626,853
– – 0.51% 41
2022
Q1 		$32.5M Sell
626,853
-362,770
-37% -$18.8M 0.53% 50
2021
Q4 		$58.4M Sell
989,623
-205,447
-17% -$10.2M 0.84% 24
2021
Q3 		$51.4M Buy
1,195,070
+610,969
+105% +$27.1M 0.84% 23
2021
Q2 		$22.9M Buy
584,101
+27,026
+5% +$1.05M 0.43% 60
2021
Q1 		$20.2M Buy
+557,075
New +$19.8M 0.45% 69
2020
Q2 		– Sell
-2,120,811
Closed -$65.7M – 178
2020
Q1 		$65.7M Buy
+2,120,811
New +$72.3M 4.69% 1

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Woodline Partners's PFE Position: Q2 2026 in Review

Woodline Partners increased its Pfizer (PFE) stake by 5.9% in Q2 2026, buying an estimated $3.16M and bringing the position to 2,154,713 shares worth $51.9M. The position accounts for 0.16% of the portfolio, ranked #169.

Woodline Partners first reported a position in PFE in Q1 2020 and has held it in 23 quarters since. The position peaked at $65.7M in Q1 2020. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Woodline Partners held 2,154,713 shares of Pfizer worth $51.9M as of Q2 2026.
  • Woodline Partners bought 120,871 Pfizer shares in Q2 2026, an estimated $3.16M.
  • Pfizer made up 0.16% of Woodline Partners's portfolio in Q2 2026, its #169 holding.
  • Woodline Partners first reported a position in Pfizer in Q1 2020 and has held it in 23 quarters since.
  • Woodline Partners's Pfizer position peaked at $65.7M in Q1 2020.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.